Alzheimer’s disease, frontotemporal dementias, progressive supranuclear palsy, Corticobasal degeneration, Clinical Trial Study
< Back to Find a Trial

A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel Cohort Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of Intravenously Infused BIIB092 in Patients With Four Different Primary Tauopathy Syndromes

ID
NCT03658135
Condition Studied
Corticobasal Degeneration
Familial Frontotemporal Degeneration
Primary Progressive Aphasia
Other
Phase
Phase I
Status
Closed
Intervention
BIIB092
Principal Investigator

Please go to ClinicalTrials.gov for more information.